Filing metadata

Accession number
0001209191-23-039352
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Jun 23, 2023
Reporting period
Jun 21, 2023
Description
Insider transaction

Explore SEC Filings Hub